Therapeutic drug monitoring as predictive marker of mucosal healing in Crohn's disease patients treated with anti-TNF: a prospective multi-centre study

被引：0
|
作者：
Bertani, L. [1 ]
Bodini, G. [2 ]
Mondello, G. [1 ]
Mumolo, M. G. [3 ]
Maltinti, S. [1 ]
Baldissarro, I. [2 ]
Tapete, G. [1 ]
Albano, E. [1 ]
Ceccarelli, L. [3 ]
Crespi, M. [2 ]
Savarino, V. [2 ]
Marchi, S. [1 ]
Costa, F. [3 ]
机构：
[1] Univ Pisa, Dept New Technol & Translat Sci Med & Surg, Pisa, Italy
[2] Univ Genoa, Dept Internal Med, Gastroenterol Unit, Genoa, Italy
[3] Pisa Univ Hosp, Dept Gen Surg & Gastroenterol, Pisa, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.700
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P576
引用
收藏
页码：S402 / S403
页数：3
相关论文
共 50 条
  • [31] Mucosal Healing of Small Bowel Crohn's Disease After Anti-TNFα Therapy Assessed by Capsule Endoscopy
    Machkova, Nadezda
    Duricova, Dana
    Bortlik, Martin
    Hrdlicka, Ludek
    Lukas, Martin
    Lukas, Milan
    GASTROENTEROLOGY, 2013, 144 (05) : S773 - S773
  • [32] Therapeutic Drug Monitoring, Mucosal Healing, Deep Remission: The Path to Nirvana in Crohn's Disease?
    Moss, Alan C.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (03) : 432 - 433
  • [33] Loss of response of anti-TNF in Crohn's disease patients single-centre experience
    Atanassova, A.
    Georgieva, A. C.
    Mirchev, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S434 - S434
  • [34] Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease: A Prospective Study
    Paul, Stephane
    Del Tedesco, Emilie
    Marotte, Hubert
    Rinaudo-Gaujous, Melanie
    Moreau, Amelie
    Phelip, Jean-Marc
    Genin, Christian
    Peyrin-Biroulet, Laurent
    Roblin, Xavier
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (12) : 2568 - 2576
  • [35] Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease: A Prospective Study
    Paul, Stephane
    Del Tedesco, Emilie
    Marotte, Hubert
    Clavel, Lea
    Phelip, Jean Marc
    Peyrin-Biroulet, Laurent
    Roblin, Xavier
    GASTROENTEROLOGY, 2013, 144 (05) : S92 - S92
  • [36] Agalactosyl IgG predicts therapeutic effect of anti-TNF agents in patients with Crohn's Disease
    Araki, M.
    Shinzaki, S.
    Iijima, H.
    Yamaguchi, T.
    Kawai, S.
    Hiyama, S.
    Inoue, T.
    Hayashi, Y.
    Watabe, K.
    Tsujii, M.
    Miyoshi, E.
    Takehara, T.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S259 - S260
  • [37] THE INCIDENCE OF CARDIOVASCULAR EVENTS IN PATIENTS WITH CROHN'S DISEASE TREATED WITH VEDOLIZUMAB AND ANTI-TNF THERAPIES
    Cross, Raymond K.
    Osterman, Mark T.
    Panaccione, Remo
    Afzali, Anita
    Song, Xue
    Shi, Nianwen
    Ding, Yao
    Wang, Anthony
    GASTROENTEROLOGY, 2017, 152 (05) : S577 - S578
  • [38] Prospective Evaluation of the Achievement of Mucosal Healing with Anti-TNF-α Therapy in a Paediatric Crohn's Disease Cohort
    Nuti, Federica
    Civitelli, Fortunata
    Bloise, Silvia
    Oliva, Salvatore
    Aloi, Marina
    Latorre, Giuseppe
    Viola, Franca
    Cucchiara, Salvatore
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (01): : 5 - 12
  • [39] Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
    Eun, Chang Soo
    GUT AND LIVER, 2017, 11 (01) : 3 - 4
  • [40] Efficacy of therapeutic drug monitoring of anti-TNF therapy in the control of patients with inflammatory bowel disease
    Bernardo, S.
    Fernandes, S.
    Goncalves, A. R.
    Baldaia, C.
    Valente, A.
    Moura Santos, P.
    Correia, L.
    Velosa, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S308 - S309
12345